RUN Oncology
32375142 2020. Perspective: SARS-CoV-2, COVID-19 and Haematologists
32346656 ä. Implementation of a Novel Remote Physician SBRT Coverage Process during the Coronavirus Pandemic
32379056 2020. Modified management mode for colorectal cancer during COVID-19 outbreak - a single-center experience
32304435 ä. The Impact of the COVID-19 Pandemic on Cancer Patients
32219410 ä. A War on Two Fronts: Cancer Care in the Time of COVID-19
32201224 2020. Managing COVID-19 in the oncology clinic and avoiding the distraction effect
32243893 ä. A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore
32278879 ä. Testing for COVID-19 in lung cancer patients
32278878 ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak
32330540 ä. Management of hepatocellular carcinoma in the time of COVID-19
32301804 2020. A Multidisciplinary Team Approach for Triage of Elective Cancer Surgery at the Massachusetts General Hospital During the Novel Coronavirus COVID-19 Outbreak
32285279 ä. Cancer Surgery and COVID19
32270420 ä. Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations
32278755 ä. COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement from Thoracic Surgery Outcomes Research Network
32212779 2020. Cancer Care Delivery Challenges Amidst Coronavirus Disease - 19 (COVID-19) Outbreak: Specific Precautions for Cancer Patients and Cancer Care Providers to Prevent Spread
32313215 ä. Prevention and control strategies for the diagnosis and treatment of cancer patients during the COVID-19 pandemic
32203269 ä. The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage
32367075 ä. COVID-19 pandemic and impact on hematopoietic stem cell transplantation
32313181 ä. Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy Estote parati
32298807 ä. Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
32305359 ä. American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplant and Cellular Therapy Patients in the United States
32339662 ä. Addressing the Impact of the Coronavirus Disease (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices
32353701 2020. Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians
32173855 2020. Care of haematology patients in a COVID?19 epidemic
32303717 ä. Caring for our cancer patients in the wake of COVID-19
32180224 2020. How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID?19 threat?
32334323 ä. Recommendations for Triage, Prioritization and Treatment of Breast Cancer Patients During the COVID-19 Pandemic
32333293 ä. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic the COVID-19 pandemic breast cancer consortium
32334674 2020. Covid-19, la Societe francaise du cancer (SFC) et le BulletinduCancer
32307107 ä. Recommandations de la Societe Francaise de Chirurgie Oncologique (SFCO) pour l?orga" width="940" height="350" frameborder="0" scrolling="auto"> tion de la Chirurgie Oncologique durant l epidemie de COVID-19
32278467 ä. COVID-19 et personnes suivies pour un cancer du sein-: recommandations pour la pratique clinique ...
32265035 2020. Options therapeutiques de prise en charge des sarcomes durant la pandemie COVID-19: propositions du groupe sarcome francais
32229048 2020. Infection SARS-CoV-2/COVID 19 et cancers solides:...
32245603 2020. Options therapeutiques en cancerologie genito-urinaire en periode epidemique du COVID-19
32343116 2020. Lifesaving cancer surgeries need to be managed appropriately during the COVID-19 pandemic
32343118 2020. Guidance for management of cancer surgery during the COVID-19 pandemic
32312609 ä. Full Spectrum of Cancer Patients in SARS-CoV-2 Infection Still Being Described
32359847 ä. Challenges and Consequences of COVID-19 in the Management of Anorectal Cancer: Coming Together Through Social Distancing
32354668 ä. Effect of COVID-19 pandemic on cancer clinician decision making: Known knowns and known unknowns
32360351 ä. Interventional oncology at the time of COVID-19 pandemic: problems and solutions
32291167 ä. Covid-19 and cancer patients: Choosing wisely is the key
32322892 ä. Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency
32294611 2020. A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19?positive patients with cancer
32368252 2020. Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis such as the COVID-19 pandemic
32346393 2020. COVID-19 and its ramifications for cancer patients in low-resource settings: Ghana as a case study
32269597 2020. Upheaval in cancer care during the COVID-19 outbreak
32346394 2020. Additional challenges faced by cancer patients in Gaza due to COVID-19
32346392 2020. Cancer care in the time of COVID-19?a perspective from Pakistan
32303485 ä. French consensus on management of head and neck cancer surgery during COVID-19 pandemic
32338298 ä. The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic
32368727 ä. Testing for COVID-19 in patients with cancer
32329810 2020. In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention?
32285027 2020. Breast Cancer Diagnosis, Treatment and Follow-Up During COVID-19 Pandemic
32285026 2020. Sars-CoV-2 (COVID-19) Outbreak and Breast Cancer Surgery in Turkey
32336627 ä. The need of COVID19 free hospitals to maintain cancer care
32302754 2020. Managing patients with cancer in the COVID-19 era
32359919 ä. COVID-19: The European institute of oncology as a hub centre for breast cancer surgery during the pandemic in Milan (Lombardy region, northern Italy) - A screenshot of the first month
32371040 ä. Rationalizing breast cancer surgery during the COVID-19 pandemic
32362468 ä. Cancer surgery in a time of COVID-19: Many questions, few certainties
32371041 ä. Cancer care under the outbreak of COVID-19
32336625 ä. Coronavirus outbreak: Reorganising the breast unit during a pandemic
32359918 2020. Management of Gynaecological oncology diseases during COVID-19 global pandemic
32331984 ä. Surgical management of bone and soft tissue sarcomas and skeletal metastases during the COVID-19 pandemic
32312591 ä. Cancer care under the outbreak of COVID-19: A perspective from Italian tertiary referral center for surgical oncology
32307215 ä. Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres
32345523 ä. The Shifting Landscape of Genitourinary Oncology During the COVID-19 Pandemic and how Italian Oncologists Reacted: Results from a National Survey
32312544 ä. Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic
32360050 2020. VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic
32349934 ä. The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead?
32349928 ä. Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guerin for High-risk Non?muscle-invasive Bladder Cancer During the COVID-19 Pandemic
32349936 ä. Balancing the Effects of COVID-19 Against Potential Progression and Mortality in High-risk Prostate Cancer
32323581 ä. The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience
32266838 ä. The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic
32370991 ä. COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies
32222433 ä. Recommandations pour la prise en charge chirurgicale des cancers gynecologiques en periode de pandemie COVID-19 - Groupe FRANCOGYN pour le CNGOF
32320812 ä. Prise en charge des cancers du sein pendant la pandemie de COVID 19: le CNGOF se mobilise
32349579 ä. COVID-19: the use of immunotherapy in metastatic lung cancer
32290754 ä. Do checkpoint inhibitors compromise the cancer patients? immunity and increase the vulnerability to COVID-19 infection?
32212881 ä. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
32351285 ä. The Need for Prioritizing Cancer Surgeries Amidst the COVID-19 Pandemic
32316337 2020. COVID-19 Pandemic and the Crisis of Health Systems: The Experience of the Apulia Cancer Network and of the Comprehensive Cancer Center Istituto Tumori "Giovanni Paolo II" of Bari
32178547 2020. Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19
32305443 ä. United States Cutaneous Lymphoma Consortium Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic
32342200 ä. A quick evaluation method of nosocomial infection risk for cancer hospitals during the COVID-19 pandemic
32335850 ä. Addressing the needs of cancer survivors during the COVID-19 pandemic
